These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4392840)

  • 1. Treatment of secondary disease in leukaemic mice with host-type and third-party haemopoietic cells and blood.
    Boranić M
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):309-14. PubMed ID: 4392840
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cyclophosphamide on the ability of graft-versus-host reaction to suppress leukaemia in mice.
    Boranić M; Tonković I
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):314-20. PubMed ID: 4403351
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplantation: introduction.
    Mathé G; Oldham R
    Transplant Proc; 1974 Dec; 6(4):333-4. PubMed ID: 4155149
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 6. Graft-vs-leukemia and moderation of graft-vs-host reaction in transplantation therapy of viral leukemia.
    Okunewick JP; Meredith RF; Raikow RB; Brozovich BJ; Magliere K
    Exp Hematol; 1981 Aug; 9(7):754-65. PubMed ID: 7032959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantability of leukaemia from leukaemic mice after irradiation and injection of allogeneic spleen cells.
    Boranić M
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):104-9. PubMed ID: 4909999
    [No Abstract]   [Full Text] [Related]  

  • 8. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
    Boranić M; Tonković I
    Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cells circulating in the blood.
    Goodman JW
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):149-50. PubMed ID: 4392667
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocompetent cell functions in mice infected with Friend leukemia virus.
    Bennett M; Steeves RA
    J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
    Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
    Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
    [No Abstract]   [Full Text] [Related]  

  • 15. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
    Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
    Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow chimeras in man and animals.
    Thomas ED; Storb R; Epstein RB
    Hamatol Bluttransfus; 1970; 9():86-95. PubMed ID: 4396279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Secondary disease following transplantation of homologous bone marrow to irradiated animals].
    Tumanian MA; Izvekova AV
    Med Radiol (Mosk); 1967 May; 12(5):71-3. PubMed ID: 4392016
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytology and histology of haemopoietic cell transplantation under the influence of ALS in mice. II. The effect of marrow from donors pretreated with antilymphocyte serum (ALS) on the recipient.
    Thierfelder S; Rodriguez-Paradisi E; Mempel W; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):121-9. PubMed ID: 4395674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft-versus-host reaction modified by in vitro preincubation of marrow with subcellular antigen.
    Uphoff DE; Draper LR
    J Natl Cancer Inst; 1971 Jan; 46(1):139-41. PubMed ID: 4396090
    [No Abstract]   [Full Text] [Related]  

  • 20. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.